✦ LIBER ✦

Treatment of Ph1-positive chronic myelogenous leukaemia with recombinant interferon alfa-2b: A case report of complete cytogenetic response

✍ Scribed by Shigeru Shirakawa; Tohru Kobayashi; Kazuhiro Nishii; Kenkichi Kita

Book ID: 119157062
Publisher: Elsevier Science
Year: 1991
Weight: 114 KB
Volume: 27
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(91)90565-u

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evolving modalities of treatment with in

Evolving modalities of treatment with interferon alfa-2b for Ph1-positive chronic myelogenous leukaemia

✍ Enrica Morra; Giuliana Alimena; Mario Lazzarino; Anna Marina Liberati; Enrico Mo 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 528 KB

MALES WITH XO Ph1-POSITIVE CELLS: A CYTO

MALES WITH XO Ph1-POSITIVE CELLS: A CYTOGENETIC AND CLINICAL SUBGROUP OF CHRONIC MYELOGENOUS LEUKAEMIA? : Report of a Case

✍ Bent Pedersen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 756 KB

Recombinant interferon alfa 2 a in the t

Recombinant interferon alfa 2 a in the treatment of patients with early stage B chronic lymphocytic leukaemia

✍ E. N. McSweeney; F. J. Giles; C. P. Worman; A. P. Jewel; C. P. Tsakona; A. V. Ho 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 606 KB

A multicentre study of a randomized ther

A multicentre study of a randomized therapeutic protocol in previously untreated patients with Ph1-positive chronic myelogenous leukaemia: Interferon alfa-2b and hydroxyurea with or without cytosine arabinoside, preliminary results

✍ François Guilhot; Jean-Pierre Lamagnère; Jean Luc Harousseau; Hervé Tilly; Phili 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 119 KB

Lymphoblastoid interferon alfa-n1 improv

Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trial

✍ Geoffrey C. Farrell; Bruce R. Bacon; Robert D. Goldin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

The aim of this study was to compare the short-term and long-term efficacy and safety of lymphoblastoid interferon with a recombinant interferon alfa (IFN-␣) in a 24-week treatment course for chronic hepatitis C. One thousand seventy-one patients with chronic hepatitis C were randomized to receive l

Treatment with peginterferon alfa-2a (40

Treatment with peginterferon alfa-2a (40KD) (PEGASYS®) results in improved rates of response compared to conventional interferon in patients with HBEAG positive chronic hepatitis B harboring HBV genotypes B or ‘difficult-to-treat’ genotype C

✍ W.G.E. Cooksley; M.-Y. Lai; T. Piratvisuth; Y.-J. Wang; V. Mahachai; Y.-C. Chao; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 135 KB